Intermediate doses of cytarabine plus granulocyte–colony‐stimulating factor as an effective and safe regimen for hematopoietic stem cell collection in lymphoma patients with prior mobilization failure

Publisher： John Wiley & Sons Inc

E-ISSN： 1537-2995|55|4|875-879

ISSN： 0041-1132

Source： TRANSFUSION, Vol.55, Iss.4, 2015-04, pp. : 875-879

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cyclophosphamide plus granulocyte‐colony stimulating factor for hematopoietic stem cell mobilization in patients with multiple myeloma

By  

JOURNAL OF CLINICAL APHERESIS, Vol. 31, Iss. 5, 2016-10 ,pp. : 423-428

John Wiley & Sons Inc

Access to resources Recommend Favorite

Plerixafor and granulocyte‐colony‐stimulating factor for mobilization of hematopoietic stem cells for autologous transplantation in Chinese patients with non−Hodgkin's lymphoma: a randomized Phase 3 study

By  

TRANSFUSION, Vol. 58, Iss. 1, 2018-01 ,pp. : 81-87

John Wiley & Sons Inc

Access to resources Recommend Favorite

Prediction of hematopoietic stem cell yield after mobilization with granulocyte–colony‐stimulating factor in healthy unrelated donors

By  

TRANSFUSION, Vol. 55, Iss. 12, 2015-12 ,pp. : 2855-2863

John Wiley & Sons Inc

Access to resources Recommend Favorite

Evaluation of Dutch guideline for just‐in‐time addition of plerixafor to stem cell mobilization in patients who fail with granulocyte–colony‐stimulating factor

By  

TRANSFUSION, Vol. 55, Iss. 5, 2015-05 ,pp. : 1021-1027

John Wiley & Sons Inc

Access to resources Recommend Favorite

Biosimilar granulocyte–colony‐stimulating factor for healthy donor stem cell mobilization: need we be afraid?

By  

TRANSFUSION, Vol. 55, Iss. 2, 2015-02 ,pp. : 430-439

John Wiley & Sons Inc

Access to resources Recommend Favorite